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Abstract
Background: The transdermal application of substances represents an elegant approach to overcome side effects
related to injections or oral treatment. Due to benefits like a constant plasma level, no pain during application and
a simple therapeutic regime, the optimization of formulations for transdermal drug delivery has gained interest in
the last decades. Ibuprofen is a non-steroidal anti-inflammatory compound which is nowadays often used
transdermally. The objective of this work was to conduct a study on the effect of different 5% ibuprofen
containing formulations (Ibutop
® cream, Ibutop
® gel, and ibuprofen solution in phosphate buffered saline) on the
in vitro-percutaneous permeation of ibuprofen through skin to emphasise the importance of the formulation on
percutaneous permeation and skin reservoir.
Methods: The permeation experiments were conducted in Franz-type diffusion cells according to OECD guideline
428 with 2 mg/cm
2 ibuprofen formulation on each skin sample. Ibuprofen was analysed in the receptor fluid and
extracted skin samples by UV-VIS high-performance liquid-chromatography at 238 nm. The plot of the cumulative
amount of ibuprofen permeated versus time was employed to calculate the apparent permeability coefficient, the
maximum flux and the lagtime, all of which were statistically analysed by One-way ANOVA.
Results: Although ibuprofen permeation out of the gel increases rapidly within the first four hours, the cream
produced the highest ibuprofen delivery through the skin within 28 hours, followed by the solution and the gel. A
significant shorter lagtime was found after gel treatment compared with the cream and the solution. After 28
hours 59% of the applied ibuprofen was found in the receptor fluid of the cream treated samples, 26% in the
solution treated samples and 21% in the samples treated with the gel. Fourfold higher ibuprofen reservoirs were
found in the solution and gel treated skin samples compared to the cream treated skin samples.
Conclusion: The present study demonstrates the importance of the formulation on transdermal drug delivery of
ibuprofen and emphasises the differences of drug storage within the skin due to the formulation. Thus, it is a
mistaken assumption that formulations comprising the same drug amount are equivalent regarding skin
permeability.
Background
T h es k i nw i t has u r f a c ea r e ao fa p p r o x i m a t e l y2m
2 in
human beings represents the largest organ of the body
and protects the latter from the intrusion of environ-
mental substances and transepidermal water loss [1].
However, the main skin barrier, the stratum corneum,i s
permeable for a small percentage of compounds with
moderate oil-water partition coefficients, small molecu-
lar weights and low melting points [2]. The stratum
corneum is a complex structure comprising hydrophilic
“dry” corneocytes embedded in a lipid matrix predomi-
nantly consisting of a mixture of ceramides, cholesteryl
and free fatty acids [3]. Compounds on the skin surface
can pass through the stratum corneum by different
ways. Beside the intercellular way through the lipid
matrix between the corneocytes, hair follicles and sebac-
eous glands are likely to be employed as diffusion shunt
ways [1]. To facilitate transdermal drug delivery for sub-
stances without permeation or to increase the amount
of substance with poor permeation profiles many studies
have been conducted (reviewed in [4]). Beside chemical
permeation enhancers such as alcohols or terpenes [4,5]
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lipid composition, physical enhancers like iontophoresis,
sonophoresis or microneedles have been produced to
overcome the skin barrier [6-9]. Likewise, the formula-
tion in which a compound is applied onto the skin
determines the rate of percutaneous permeation [10], as
thermodynamic activities e.g. can vary from formulation
to formulation. Although in vivo- and in vitro-studies
demonstrate the vehicle dependence of the permeation
profile of ibuprofen, the variety of ingredients used can
barely be used to predict ibuprofen delivery out of these
formulations [11,12]. Consequently, comparative studies
with effective formulations are necessary to characterise
the effectiveness of the marketed products such as
creams, gels, sprays, mousses and ointments.
Thus, the object of the present study was to examine
the in vitro permeation profile of ibuprofen out of two
marketed formulations and ibuprofen solution, all of
which contained 5% ibuprofen, through skin to show
the impact of the vehicle on transdermal drug delivery.
Moreover, the ibuprofen content in the skin samples
was measured to investigate whether the formulation
determines the drug reservoir within the skin.
Methods
Chemicals
All reagents used for the present study were of the high-
est purity available. The salts used for the buffer pro-
duction were obtained from Merck (Darmstadt,
Germany) and methanol was obtained from Applichem
(Darmstadt, Germany).
Membranes
The skin was obtained from udders of Holstein Friesian
cows at the slaughterhouse. In brief, skin flaps were
removed from udders immediately after slaughter. The
flaps were washed with cold water before they were
stored at -20°C until use (maximum 3 weeks). Prior to
the experiment, the skin flaps were defrosted and an
electrical dermatome (Zimmer, Eschbach, Germany) was
employed to obtain 500 μm( ±1 0 0μ m) thick split skin
samples.
Ibuprofen formulations
The ibuprofen 5% w/w formulations utilised in the pre-
sent study were Ibutop
® gel (mibe GmbH Arzneimittel,
Brehna, Germany) and Ibutop
® cream (Dr. Henk
Pharma GmbH, Sankt Augustin/Bonn, Germany) as well
as an ibuprofen (Sigma-Aldrich, Steinheim, Germany)
containing solution (in phosphate buffered saline (PBS,
pH 7.4; 1 l contains 0.2 g KCl, 8.0 g NaCl, 0.2 g
KH2PO4,1 . 4 4gN a 2HPO4 ×2 H 2Oa n dd e i o n i s e d
water)). The ingredients of the formulations are pre-
sented in Table 1.
In-vitro permeation experiments
The permeation experiments were conducted in skin
samples of four to six animals in duplicate under non-
occlusive conditions according to OECD guideline 428
[13]. Prior to the experiment both the skin samples were
cut into pieces of 4 cm
2 which were incubated in PBS for
30 minutes. They were mounted between the donor and
the receptor chamber of Franz-type diffusion cells (with
the stratum corneum pointing to the donor chamber), all
of which were maintained at 32°C by a water bath. The
receptor chambers were filled with 12 ml sonicated PBS
and stirred continuously with a magnetic bar (500 rpm).
Just before administration of the different formulations
on the membrane surface a 400 μl sample was withdrawn
from the receptor chamber. Additional samples were
taken at the following times: 0.5, 1, 2, 3, 4, 6, 22, 24, 26
and 28 hours. After each sample withdrawal the receptor
chamber was refilled with 400 μl PBS.
Ibuprofen measurement in the skin samples
The amount of ibuprofen in the skin samples was deter-
mined after completion of the diffusion experiment.
Therefore, the skin samples were removed from the dif-
fusion cells and rinsed with cold water. A biopsy-punch
with a diameter of 6 mm was employed to obtain a skin
biopsy from the diffusion area, which was shaken with
10 μlH 2SO4 (2 N) and 800 μl methanol for 30 minutes.
After 24 hours incubation at 4°C the supernatant was
collected and 190 μl McIlvaine citrate buffer (pH 2.2; 1 l
contains 20.8 g citric acid anhydrous, 0.4 g Na2HPO4 ×
2H2O and deionised water) were added. The recovery
was approximately 85-90%.
Analysis
Ibuprofen in both the receptor medium samples and the
skin samples was analysed by a validated UV-VIS high-
performance liquid-chromatography methodology using
a Merck LiChroCART 125-4 Lichrospher 100 RP18e (5
mm) column (Darmstadt, Germany) and a model 168
UV-VIS detector from Beckman (Fullerton, CA, USA) at
238 nm [14]. The mobile phase which was a 80:20 (v/v)
mixture of methanol and McIlvaine citrate buffer (pH
2.2) was pumped by a 116 pump from Beckman (1.5 ml/
min). The content of ibuprofen was determined using the
external standard method. The limit of quantification
was 200 ng/ml and the limit of detection was 100 ng/ml.
The recovery results in the receptor chamber are
expressed as percentage recovery of the applied amount
of ibuprofen. The amount of ibuprofen found in the skin
samples is expressed as “skin absorption” in μg/cm
2.
Data analysis
The plot of the cumulated amount of ibuprofen versus
time was employed for the calculation of the apparent
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2008 [15] as well as for the determination of the maxi-
mum flux Jmax and the lagtime. Values from replicated
experiments (2 replicates per formulation) in skin from
the same individual were used as average. Differences in
the permeation parameters (Papp,J max, lagtime, and
recovery) were evaluated using One-way ANOVA (analy-
sis of variance) followed by Tukey’s multiple comparison
test (GraphPad Prism 4.01 (GraphPad Software Inc., San
Diego, USA)) with a significance level of p < 0.05.
Results
After administration of three different ibuprofen con-
taining formulations on bovine udder skin substantial
differences in the permeation profiles were obtained
(Figure 1A). The highest ibuprofen permeation was
found after application of the cream formulation fol-
l o w e db yam o d e r a t ei b u p r o f en permeation out of the
solution and the lowest ibuprofen delivery out of the
gel, despite a sharp increase of the ibuprofen permeation
within the first two hours after gel administration.
Nevertheless, the Papp-values obtained from the linear
p a r to ft h ep l o tw e r en o ts i g n i f i c a n t l yd i f f e r e n tb e t w e e n
the groups (Figure 1B and Table 2). After 28 hours sig-
nificant higher ibuprofen contents were found to have
been passed through the skin after topical administra-
tion of the cream (Table 2) by comparison to the gel
and the solution. However, the highest ibuprofen reser-
voir in the skin samples was found in the samples trea-
ted with the solution, closely followed by the gel, while
fourfold lower amounts of ibuprofen were determined
in the cream treated skin samples (Table 2). Due to a
high standard deviation, these differences were not sta-
tistically significant. Significant shorter lagtimes were
found after gel application in comparison to the admin-
istration of the cream or the solution (Table 2).
Discussion
The present study was conducted to investigate the
influence of the galenic formulation on the
Table 1 Ingredients of topical formulations containing ibuprofen 5%
Ibutop
® gel Ibutop
® cream Ibuprofen solution
Active ingredient Ibuprofen 5% Ibuprofen 5% Ibuprofen 5%
Excipients Dimethyl isosorbide Sodium methyl hydroxybenzoate Phosphate buffered saline (pH 7.4)
2-Propanol Medium chain triglycerides
Poloxamer Glycerol-monostearate
Medium chain triglycerides Macrogol stearate 1500
Lavender oil Macrogol stearate 5000
Orange blossom Propylenglycol
Purified water Xanthan gum
Purified water
Figure 1 Skin permeation of ibuprofen. A: Ibuprofen permeation of bovine udder skin samples in vitro following application of topical
formulations containing ibuprofen 5% (mean + standard deviation) and B: the obtained apparent permeability coefficients (boxplots with
minimum and maximum; n = 5-6).
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within the skin. Although the examined formulations
comprised the same amount of ibuprofen (5% w/w),
considerable differences in the permeation profiles were
determined comparable with Hadgraft et al. (2003) [11].
The cream formulation was the most efficient vehicle
for ibuprofen permeation through the skin as it reached
twofold to threefold higher amounts of ibuprofen in the
receptor chamber within 28 hours. The permeation of
the ibuprofen solution ranged between the permeation
of the cream and of the gel which offered a lower ibu-
profen delivery through the skin. Despite a sharp initial
increase in the permeation of ibuprofen out of the latter,
only a small percentage of ibuprofen was delivered into
the receptor fluid after application of the gel formula-
tion over time. It has to be taken into consideration that
ibuprofen represents a non-steroidal anti-inflammatory
drug which is predominantly taken due to its rapid pain
relief and anti-inflammatory action. Thus, a high per-
centage of permeated ibuprofen results in the best clini-
cal benefits. It is likely, that the application of the gel
leads to a fast and effective ibuprofen concentration in
the organism, whereas the data of the present in vitro
study do not inform about effective plasma levels after
topical administration in vivo. It has to be discussed
whether the sharp incline of the ibuprofen permeation
out of the gel is prejudicial to the patient compared to a
s t e a d yi b u p r o f e np e r m e a t i o ni nt h ef i r s th o u r sa f t e r
administration. Since high amounts of ibuprofen were
found to be in the skin after 28 hours gel treatment, it
can be supposed that, on condition that the compara-
tively low permeation is sufficient to produce efficacious
blood levels, the gel offers advantages concerning a
long-term treatment. Thus, the skin supplies the body
continuously with ibuprofen without the need of a fol-
low-up treatment, even after removal of the remained
formulation on the skin surface.
The fact that different formulations comprising ibu-
profen as active compound impact the amount of trans-
dermal drug delivery confirms findings of Hadgraft et al.
2003 [11] and is likely to be explained by partition and
diffusion phenomena. Therefore, 5% ibuprofen contain-
ing formulation applied onto the skin can result in
unpredictable ibuprofen fluxes, which have to be com-
pared to effective therapeutics. Furthermore, the drug
reservoir within the skin is considerably determined by
the galenic formulation. Surprisingly, the topical applica-
tion of the self-made ibuprofen solution as control
resulted in a permeation rate in the middle of the mar-
keted products, despite the lacking of supplementation
of permeation enhancers like 2-propanol or medium
chain triglycerides, all of which interact with the stratum
corneum.
Conclusion
The present investigation demonstrates the importance
of vehicle formulation on transdermal drug delivery of
ibuprofen and highlights the differences of drug reser-
voirs within the skin due to different galenics.
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